Activity value 66france Supplier,Last transaction date:
2023-05-09
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for sarl cg- biotechnologie pharma from 2022 to 2023.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2023, the company has completed 207 transactions, with a transaction quantity of 276 and a transaction weight of 95.
YearTransactionsQuantityWeight
2022301456165
202320727695
Bill of lading data
<
1/15
>
Trade date
2023/05/09
B/L No.
23341453im00260189
Suppliers
sarl cg- biotechnologie pharma
Buyers
genport laboratuvar ürünleri sanayi ve ticaret limited şirketi
POLs
——
PODs
istanbul havalimani
Supply area
France
Purchas area
Turkey
Weight
0.03kg
Amount
40.33
Hs code
291469800014
Product tags
k3,dione,mena
Product description
MENADİONE (K3)
Expand
Trade date
2023/05/09
B/L No.
23341453im00260189
Suppliers
sarl cg- biotechnologie pharma
Buyers
genport laboratuvar ürünleri sanayi ve ticaret limited şirketi
POLs
——
PODs
istanbul havalimani
Supply area
France
Purchas area
Turkey
Weight
0.24kg
Amount
277.39
Hs code
293299009029
Product tags
c acid
Product description
(+)-USNİC ACİD
Expand
Trade date
2023/05/09
B/L No.
23341453im00260189
Suppliers
sarl cg- biotechnologie pharma
Buyers
genport laboratuvar ürünleri sanayi ve ticaret limited şirketi
sarl cg- biotechnologie pharma is france Supplier,
and primarily engages in the import and export business of products such as test kit,kull,i kit.
According to the 52wmb.com global trade database, as of 2023-05-09, the company has completed 1182 international trades,
with its main trading regions covering turkey etc.
The core products include HS382200009019,HS350790900019,HS382290000019 etc,
and its main trading partners are genport laboratuvar ürünleri sanayi ve ticaret limited şirketi,suarge biyoteknoloji sanayi ve ticaret limited şirketi.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on sarl cg- biotechnologie pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.